Ketosis-prone type 2 diabetes ("Flatbush diabetes") carries features of both classical type 1 and type 2 diabetes and is highly prevalent in African populations. The disease, which is highly ketosis-prone, but neither chronically insulinopenic nor autoimmune, is discussed regarding pathogenesis, diagnosis and treatment from a patient case perspective.
Keywords: Flatbush diabetes; GLP-1–glucagon-like peptide-1; SGLT 2 inhibitor; atypical diabetes; ketosis.
Copyright © 2019 Sjöholm.